Health Care/Hospital

Shionogi Partners with Cloudera to Accelerate R&D and Achieve Data-Driven Innovation in Pharmaceuticals

Discovery-based pharmaceutical company in Japan leverages Cloudera for greater speed to insights across its research, development, and post-market value chain. SINGAPORE, April 6, 2022 /PRNewswire/ -- Cloudera, the hybrid data cloud company, today announced that Japanese pharmaceutical company,Sh...

2022-04-06 08:00 2437

Everest Medicines Announces that Topline Results from Chinese Subpopulation Consistent With Global Phase 3 NefIgArd Study Part A Analysis

SHANGHAI, April 6, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inGreater China and other parts of Asia, announced today t...

2022-04-06 08:00 2008

Mindtree Invests in COPE Health Solutions to Accelerate its Healthcare Business

NEW YORK, April 6, 2022 /PRNewswire/ -- Mindtree , a global technology services and digital transformation company, today announced that it has made a strategic investment inCOPE Health Solutions , a leading U.S. healthcare consulting, ...

2022-04-06 07:13 1828

Digital Engagement Continues to Soar Amongst Biopharmas in APAC

SYDNEY, April 6, 2022 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today released 2021 industry-wide Veeva Pulse data that shows the continued growth of digital engagement across theAsia Pacific* life sciences industry. Since the start of the COVID-19 pandemic, digital comm...

2022-04-06 05:00 2603

MGC Pharmaceuticals Enters Partnership with Sciensus Rare for Distribution of Cannabinoids to Treat Refractory Epilepsy, Dementia and Alzheimer's in the EU and UK

LONDON, April 5, 2022 /PRNewswire/ -- MGC Pharmaceuticals Ltd. (LSE: MXC, ASX: MXC, OTC:MGCLF), a European based bio-pharma company specializing in the production and development of phytomedicines, has signed an exclusive distribution agreement withSciensus Rare

2022-04-05 14:00 2121

Elekta and GE Healthcare collaborate to expand access to precision radiation therapy solutions

SINGAPORE, April 5, 2022 /PRNewswire/ -- Elekta (EKTA-B.ST) and GE Healthcare announced today that they have signed a global commercial collaboration agreement in the field of radiation oncology, enabling them to provide hospitals a complete offering across imaging and therapy for cancer patients...

2022-04-05 13:30 2666

TraceLink Announces Product Availability Intelligence, Enabling Manufacturers to Predict Drug Shortages up to 90 Days in Advance with Greater Than 80% Accuracy

Opus™, the operating platform for Industry 4.0, provides the infrastructure to predict drug shortages by applying Artificial Intelligence to analyze the movement of more than 30 billion products tracked within the world's largest Healthcare and Life Sciences network. BOSTON, April 5, 2022 /PRNew...

2022-04-05 13:00 2250

TraceLink Launches its Opus Compliance Framework with the Release of the Brazil Compliance Solution on the Opus Platform

The Opus™ Compliance Framework Enables Rapid Development of Compliance Solutions To Keep Pace With Increasing Country Mandates BOSTON, April 5, 2022 /PRNewswire/ -- TraceLink Inc, the leading digital network platform company, announces the release of its Opus™ Compliance Framework with the relea...

2022-04-05 13:00 1619

Indonesia's G20 Health Working Group (HWG) Meeting Series Work Towards Standardization of Global Health Protocols

JAKARTA, April 5, 2022 /PRNewswire/ -- Assuming the presidency in the upcoming G20 summit,Indonesia has begun the Health Working Group (HWG) meeting series that took place on28-30 March 2022 in Yogyakarta, Indonesia. Indonesia's Ministry of H...

2022-04-05 09:00 3162

Sirnaomics Doses First Subject in Phase I Clinical Trial of STP707 for the Treatment of Liver Fibrosis in Primary Sclerosing Cholangitis

HONG KONG, April 4, 2022 /PRNewswire/ -- Sirnaomics Ltd. ("Sirnaomics," stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today dose administration for the first subject in a U.S. Phase I clinical tr...

2022-04-04 21:31 2664

AMR Action Fund Announces First Investments in Adaptive Phage Therapeutics and Venatorx Pharmaceuticals

Deals mark an important step toward AMR Action Fund's goal of bringing two to four new antibiotics to market to take on growing threat of drug-resistant bacteria BOSTON, April 4, 2022 /PRNewswire/ -- The AMR Action Fund, the world's largest public-private partnership investing in biotech compani...

2022-04-04 18:00 2055

Ascletis Announces Completion of First Sale of Its Ritonavir Tablets in Zhejiang Province

HANGZHOU, China and SHAOXING, China, April 4, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672) today announces that the first sale of its ritonavir tablets inZhejiang Province has been completed. On April 3, 2022, Ascletis' distributor, Zhejiang Int'l Medicine Co., Ltd. ("Zhejiang Int'l"),...

2022-04-04 17:10 2482

International Virchow Prize for Global Health launched

Highly prestigious award endowed with €500,000 to uphold the United Nations 2030 Agenda - Picture is available at AP Images (http://www.apimages.com ) - BERLIN, April 4, 2022 /PRNewswire/ -- The nomination phase of the newly established Virchow Prize for Global Health ...

2022-04-04 16:00 1507

Clarivate Healthcare Business Insights Announces 2021 Revenue Cycle Awards Recipients

Winners include Liberty Hospital, four Ardent Health Services hospitals, University of Iowa Hospitals & Clinics and Novant Health LONDON, April 4, 2022 /PRNewswire/ -- Today, Clarivate Healthcare Business InsightsTM , a part of Clarivate Plc (NYSE: CLVT), a global leader in providing trusted inf...

2022-04-04 16:00 2103

SeaX Ventures Launches $60 Million Fund II to Help International Startups Expand in Southeast Asia

BANGKOK, April 4, 2022 /PRNewswire/ -- SeaX Ventures (Southeast Asia Exponential Ventures) announced today the close of its second fund to help accelerate the growth of global startups throughoutSoutheast Asia. The fund is dedicated to investing in companies working on truly transformational opp...

2022-04-04 16:00 5634

B.I.G. VISION® FOR ALL from Rodenstock: Optimal vision with biometric lenses for everyone

MUNICH, April 4, 2022 /PRNewswire/ -- Everyone's appearance is so different and individual and so too are their eyes. Rodenstock recognised that every eye is different and developed an innovative technology that determines the personal biometrics of the eye from several thousand measuring points ...

2022-04-04 15:48 2162

Radiaction Medical Ltd. Receives FDA Clearance for its Innovative Radiation Protection System and Secures $10M for US Launch and Commercialization

TEL AVIV, Israel, April 4, 2022 /PRNewswire/ -- Radiaction Medical Ltd. ("Radiaction"), an innovative medical device company focused on radiation protection in the interventional cardiology and electrophysiology sectors, announced FDA 510(K) clearance for the m...

2022-04-04 10:00 2075

Telix, GMS and Monash Awarded $23M Federal Government Funding as part of $71M Australian Precision Medicine Enterprise (APME) Project

MELBOURNE, Australia, April 4, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it is part of a $71.2 million Australian Precision Medicine Enterprise (APME) Project, which has been awarded$23 million in Federal Government grant funding under t...

2022-04-04 09:13 2860

CanSinoBIO's COVID-19 mRNA Vaccine Receives Approval of Clinical Trial Application in China

TIANJIN, April 4, 2022 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO" of "the Company") (SSE: 688185, HKEX: 06185) today announced that the National Medical Products Administration ofChina ("NMPA") granted approval for the clinical trial application of its COVID-19 mRNA vaccine inChina. Pr...

2022-04-04 08:30 4856

Innovent Releases Results of a Phase 3 Clinical Study of IBI306 (PCSK-9 inhibitor) in Chinese Patients with Heterozygous Familial Hypercholesterolemia at the American College of Cardiology Annual Congress 2022

SAN FRANCISCO and SUZHOU, China, April 4, 2022 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major dise...

2022-04-04 08:00 3250
1 ... 211212213214215216217 ... 552